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ABSTRACT
Obesity is a major health problem and one of the biggest predictors of the development 
of chronic diseases. Variations in the Fat mass and obesity associated gene (FTO) 
have been shown to associate strongly with obesity. Among patients with severe 
obesity, there is a subpopulation that presents an eating disorder known as Binge 
Eating Disorder. Because of its expression in the hypothalamus, FTO could be 
associated with modulation of satiety and, perhaps, play a role in the genesis of BED, 
contributing to severe obesity. A search in PubMed was carried out with the following 
terms: Morbid Obesity AND FTO, FTO AND Satiety Response, Binge Eating Disorder 
AND FTO. No restriction on the date of publication, language or type of design was 
applied. Sixteen articles were found. Twelve were related to FTO and grade III obesity, 
and three were related to FTO and satiety. Ten studies were excluded. Thus, six 
articles were evaluated in this review. The scarce literature limits further conclusions 
about the potential impact of the associations with FTO in the treatment of obesity, 
but all articles included in this revision show association with at least one SNP of 
FTO. Further studies are required to clarify these associations, especially in relation 
to rs9939609 (A/T), because, up to this moment, it seems to be the one variant with 
greatest impact on obesity in humans.
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Obesity is one of the main health problems in the 21st Century. It is 
an established risk factor for conditions such as Type 2 diabetes mellitus, 
cardiovascular disease and cancer1. 
The prevalence of overweight and obesity has doubled in the last thirty 
years. In Brazil, a 2008/2009 survey of the Ministry of Health showed that 
8.9% of the population is obese. In the South of the country, 10.1% of the male 
population and 15.1% of the female population is obese. Brazilian estimates 
point out that, in the year 2025, the country will have the fifth largest prevalence 
of obesity worldwide2. Clinically, obesity is diagnosed in the presence of a 
body mass index (BMI) equal to or higher than 30 kg/m2, in adults3.
Recent studies show associations of BMI with body fat and with the the 
“Fat mass and obesity associated” (FTO) gene4, located in chromosome 
16q12.25,6. Variations in this gene (single-nucleotide polymorphisms – SNPs) 
were strongly associated with obesity and diabetes mellitus7. The association of 
FTO with human obesity has been shown in caucasian populations studies8-11. 
Besides the association with BMI and higher risk for overweight and obesity, 
SNPs in FTO have been associated with obesity and body weight5,8,11, leptin 
levels11, subcutaneous fat5,8, fat mass5,8,11 and waist circumference11.
The messenger RNA (mRNA) of FTO is expressed in the hypothalamus12, 
an area that is connected with appetite regulation; in rodents, FTO mRNA 
expression in the hypothalamus is modulated by acute food deprivation13. 
One recent study, in human adults, has found differences in the caloric intake, 
but no difference in the energy expenditure, showing that the FTO genotypes 
affect body weight mostly through caloric intake14.
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Recent research shows that, among obese 
subjects, there is a subpopulation with similar 
characteristics that does not respond to the usual 
behavioral treatment for weight loss. This group 
presents an eating disorder known as Binge Eating 
Disorder (BED)15.
Binge eating is characterized by a very high 
intake of food within two hours, followed by a feeling 
of loss of control of what and how much it is eaten. 
According to DSM IV-TR, BED is diagnosed when 
episodes happen at least twice a week, for six months, 
associated to some characteristics of loss of control, 
and are not followed by compensatory behaviors 
(such as vomiting or use of laxatives)16.
Patient medical records indicate that they have an 
early onset of obesity, high BMIs, and poor response 
to dietary treatment; they also spend more time 
involved with their diets17. An estimated frequency 
of 5-30% (and in one extreme report, 50%) of BED 
among obese patients that look for help has been 
reported. In the general population, the prevalence 
of BED is of 2-3%. In Brazil, a prevalence of 15-22% 
has been reported in patients that look for help for 
weight loss18.
Due to its expression in the hypothalamus, FTO 
may be associated with satiety modulation and, 
consequently play a role in the genesis of BED, 
contributing to severe obesity and its complications.
This article sought to report the current knowledge 
on the association of polymorphisms of FTO with 
satiety in obese individuals.
METHODS
We conducted a search in Pubmed (National Center 
for Biotechnology Information, U.S. National Library 
of Medicine), with the following associated MESH 
terms: Obesity Morbid AND FTO, Satiety Response 
AND FTO, Binge eating disorder AND FTO. We set 
no restrictions as to the date of publication, language, 
age of the subjects in each study, or type of design.
The search and analysis strategies were of a 
structured review.
Were excluded from this review: studies that 
encompassed items not related to overweight and/or 
obesity, and those with patients who had undergone 
bariatric surgery or other surgery that could interfere 
with the gastrointestinal tract. Only studies with human 
subjects were included.
RESULTS
A total of 16 articles were found; of these, 12 were 
related to FTO and grade III obesity; 3 to FTO and 
satiety; and 1 to BED and FTO. Of the studies that 
correlated FTO and obesity, seven were excluded 
because the subjects had undergone bariatric surgery, 
and two were experimental animal studies. The article 
related to BED was excluded because it was in 
low-weight patients. Thus, 6 articles were evaluated 
in this review, as illustrated Figure 1: 3 case-control 
studies; 1 review, 1 cross-sectional study and 1 brief 
communication. All of the case-control studies looked 
for the association between the genes connected to 
Figure 1: Article selection flowchart.
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FTO and obesity. These articles described control 
groups of non-obese patients and obese patients 
(obesity level II and III). In the three articles, SNPs of 
FTO (rs1421085, rs1861868, rs9939609, rs17817449) 
were studied. In the study of Attaoua et al., a dietary 
intervention was carried out in order to provide the 
same nutritional environment. All studies showed 
associations between obesity and polymorphisms 
of FTO (table 1)19,20,22.
The study by Meyre et al., shows gene associations 
(including FTO) in two life stages: childhood and 
adult obesity; it tested these associations in three 
scenarios: childhood obesity only, adult and childhood 
obesity, and adult obesity only. The study highlights 
the importance of these associations showing that 
obesity in childhood and adult life share the same 
genetic architecture21.
The study by den Hoed et al. evaluated individuals 
with an average BMI of 25 kg/m2, who received 
balanced and standardized meals (27% protein, 
45% carbohydrates, and 28% fat). After the test 
meals, hunger and satiety were evaluated through 
visual scales. In this article, five different SNPs 
were studied; one was FTO rs9939609. The authors 
found an association between the FTO rs9939609 
polymorphism, lower satiety and lower postprandial 
hunger reduction23.
The review article examined genes that contribute 
to obesity and eating behaviors in children and 
adolescents – FTO, PPARG and MC4R. The most 
frequent FTO SNP would be rs9939609, as seen in 
studies relating BMI and body fat to the SNP children 
and adolescents. A small number of studies conducted 
in children measured the indirect intake of energy 
associated with the FTO and confirmed the higher 
risk of obesity due to reduced satiety, preference for 
energy dense food and not for energy expenditure 
as suggested by the literature24.
DISCUSSION
The present review shows how scarce are studies 
on FTO when associated with morbid obesity. 
In total only four SNPs in FTO were studied and not 
all showed positive associations. Of 4 studies that 
examined rs9939609, only one found association 
with obesity. Three studies examined rs1421085; 
one found an association with obesity and in one 
there was a correlated with insulin resistance19-22.
Price et al. found an association between obesity 
and several SNPs; among them, FTO rs1421085 
showed the strongest association. This study included 
Table 1: Association of Obesity and FTO polymorphism.
Author/Year
Journal/Qualis Population Objetive Results
R Arlen Price 
(2008)19, BMC 
Medical Genetics
Women, BMI > 35kg/m2 
(cases) Women, BMI < 25kg/
m2 (controls)
Examine SNPs (rs1421085, 
rs17817449, rs9939609) to 
determine if the variability of 
FTO can be distinguished 
between cases of extreme 
obesity and normal weight 
control
There was association of 
obesity in all SNPs, the 
largest association observed 
with rs1421085
R. Attaoua (2009)20, 
Diabetes & 
Metabolism
Thin women x obese women, 
all received three diets and 
after each diet there was 
blood collection. GTT for 
obese women
Investigate genetic 
association of FTO in obese 
women in the presence of 
IRS-2
There was association of FTO 
and obesity, as well as IRS-2.
There was a correlation 





Kids with obese Family, kids 
with normal weight, thin 
adults, morbid obese adults
Association of early onset 
genome (6 year old kids) and 
obese individuals, compared 
with individuals of the same 
age and normal weight
Evidence that obesity in 
childhood and adulthood have 





Patients with obesity before 
16, patients with phenotype 
and Family history of obesity
Evaluate the association of 
variation of FTO gene, based 
on SNP rs1861868 and 
rs9939609, with hereditary 
predisposition to suffer from 
morbid obesity
There was an association 
of rs9939609 with severe 
obesity in the Spanish 
population
FTO: Fat Mass and Obesity associated, BMI: Body Mass Index, IRS-2: Insulin Receptor - 2, GTT: glucose tolerance test.
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only women, Attaoua et al. also studied only females 
and found, besides the association with obesity, a 
correlation of rs1421085 with insulin resistance. 
The relation of FTO with insulin resistance was also 
reported by Cecil20,24.
The most studied SNP in FTO is rs9939609. 
Although just one study found an association with 
obesity in this review, there are in previous studies 
a description of decreased response to satiety 
in children and adolescents when rs9939609 is 
present, confirmed in other studies25-28. As Cecil, 
Frayling et al. also identified, rs9939609 carries an 
association with a higher Body Mass Index (BMI) in 
children and adults29.
In individuals with normal weight or overweight, 
den Hoed found a variable, but significant, association 
between rs9939609 and postprandial response of 
hunger and satiety23. These data suggest that the 
rs9939609 polymorphism is a predisposing factor to 
weight gain, but not mandatory.
A study related in a Spanish population demonstrated 
a relation of rs9939609 with severe obesity in 
childhood. Individuals with two SNPs (rs1861868 
and rs9939609) had a 3.03% greater chance of 
developing severe obesity in adulthood. The impact 
of this and other eventual combinations of SNPs has 
not been properly evaluated to date22.
On the other hand, Liu et al. have not found 
associations of FTO rs9939609 with the caloric intake 
of the subjects in their review paper30. Nevertheless, 
this study did show a correlation between satiety 
and the FTO rs9939609. Being a non-systematic 
review, Liu’s findings have to be weighed in view of 
the obvious limitation.
Women are the largest population with overweight 
and obesity in Brazil2; this fact happens in most 
countries. In a study conducted in 2009, Cornes et al. 
analyzed rs9939609 and found an association 
with BMI in men and women, but with a stronger 
association in women4.
We notice that at different stages of life (childhood 
and adulthood) the association of FTO with obesity 
is similar. Meyere et al. confirm that obesity in both 
stages of life has the same genetics21.
We know the association of FTO with possible 
weight gain and increased BMI, waist circumference 
and insulin resistance, but we do not know where 
this influence begins and how FTO can be used to 
prevent obesity. Larder et al. reviewed studies of 
FTO in animal models and cell studies, and found no 
direct association with obesity-related mechanisms. 
There are still missing data to enable us to explain 
these relationships31.
All studies included in this review found positive 
associations between the FTO (and its various SNPs) 
and satiety and obesity. Unfortunately, the scarce 
literature limits further conclusions; the association 
exists, but it is not yet clear what real importance it 
carries to the problem of obesity, its mechanisms - 
particularly appetite modulation - and, eventually, 
its treatment.
FTO rs9939609 seems to be the one SNP with the 
greatest impact on obesity, it most likely influences 
body mass through some interference with satiety, 
but there are no data as to a clear relation of FTO 
with eating disorders. Further studies in humans 
will have to be designed and carried out in order to 
clarify this subject.
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